Collegium Pharmaceutical, Inc. Common Stock COLL
$35.58
+0.54%
at last close
Financials (TTM)
- Revenue
- $796.33 million
- Net Income
- $74.95 million
- Net Margin
- 9.41%
- Return on Equity
- 23.99%
- Debt-to-Equity
- —
- P/E Ratio
- 17.44
- Price / Book
- 3.69
- Price / Sales
- 1.45
Over the trailing twelve months, Collegium Pharmaceutical, Inc. Common Stock generated revenue of $796.33 million and net income of $74.95 million, a net margin of 9.41%.
At the last closing price of $35.58, COLL trades at 17.44 times trailing earnings and 1.45 times sales, with a market capitalization of $1.15 billion.
Key Stats
- Last Close
- $35.58
- Market Cap
- $1.15 billion
- 52-Week Range
- $29.19 – $50.79
- Average Volume
- 417K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.